Stacie Dusetzina shares new research that examines the link between drug companies’ charity donations and their business incentives.
Stacie Dusetzina, Ph.D.
Stacie Dusetzina, Ph.D. is a professor of health policy at Vanderbilt University School of Medicine. Her research focuses on measuring and evaluating the costs of prescription drugs. Stacie is a member of the 2022 Research Council.
Posted inCost of Care
Dems’ New Drug Pricing Deal: What You Need to Know
Stacie Dusetzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.
Posted inCost of Care
MRIs, Mammograms and the Risk of Breast Cancer Screening Cascades of Care
Stacie Dusetzina shares new research on how much extra care comes after different kinds of breast cancer screenings.
Posted inCost of Care
Ways to Save in Budget Busting Medicare Part B
Stacie Dusetzina shares new research showing the difference in spending on Part B drugs in Medicare and Medicare Advantage.
Posted inCost of Care
Saving Money on Cancer Care Is Hard
Stacie Dusetzina shares new research on the results of one of the largest efforts ever to improve care and control costs for cancer patients.
Posted inInsurance
When Picking an ACA Plan Becomes An Olympic Event
Stacie Dusetzina digs into research showing that Obamacare shorthands of “silver” and “gold” plans aren’t always helpful.
Posted inInsurance
The Perils of a Medicaid ‘Coverage Cliff’
Stacie Dusetzina on research looking at the impact Medicaid subsidies can have for costs and care for Medicare beneficiaries.
Posted inInsurance
Employer Plans Shine a Light on the Full Cost of Health Care
Stacie Dusetzina digs into the 2020 KFF Employer Benefits Survey.